Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$61.74

-0.61 (-0.98%)

, UNH

UnitedHealth

$136.62

0.15 (0.11%)

14:33
10/07/16
10/07
14:33
10/07/16
14:33

UnitedHealth plans to cover Sarepta's Exondys 51, Reuters reports

A spokesperson for UnitedHealth (UNH) confirms the insurer plans to cover Sarepta Therapeutics' (SRPT) Duchenne muscular dystrophy drug Exondys 51, according to Reuters.

SRPT

Sarepta

$61.74

-0.61 (-0.98%)

UNH

UnitedHealth

$136.62

0.15 (0.11%)

  • 18

    Oct

  • 06

    Nov

SRPT Sarepta
$61.74

-0.61 (-0.98%)

09/28/16
JMPS
09/28/16
NO CHANGE
JMPS
Street underestimating price of Sarepta drug, says JMP Securities
JMP Securities analyst Liisa Bayko expects the price of Sarepta's Exondys 51 drug will be above the company's projected annual net price of $300,000. She thinks that the price will come in "closer to $538,000 per year on a gross basis, $457,000 net of discounts and compliance." The analyst raised her price target on the shares to $90 from $60 and keeps an Outperform rating on the stock.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $68
PIPR
Overweight
Piper Jaffray ups Sarepta target to $68 on Summit deal
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.
10/05/16
ADAM
10/05/16
NO CHANGE
Target $28
ADAM
Buy
Summit Therapeutics price target raised to $28 from $14 at Canaccord
Canaccord analyst Arinda Lee raised her price target on Summit Therapeutics (SMMT) to $28 from $14 following the announcement of its collaboration and licensing agreement with Sarepta Therapeutics (SRPT). The deal calls for Sarepta to gain EU commercialization rights to Summit's pipeline of oral utrophin modulators for all patients with Duchenne muscular dystrophy. Lee reiterated her Buy rating Summit Therapeutics shares.
10/07/16
BARD
10/07/16
NO CHANGE
Target $102
BARD
Outperform
Anthem policy does not mean insurer not covering Sarepta drug, says Baird
Baird analyst Brian Skorney noted Anthem (ANTM) has categorized Sarepta (SRPT) Duchenne muscular dystrophy drug Exondys 51 as "not medically necessary" in a new coverage policy, but he cautions this "does not mean that Anthem is not covering the drug." The analyst explains that the policy means prior authorization requirements may be stricter, but he "highly doubts" that eligible patients will be denied coverage. Skorney, who adds that other large insurers appear to have favorable coverage for the drug, keeps an Outperform rating and $102 price target on Sarepta shares.
UNH UnitedHealth
$136.62

0.15 (0.11%)

09/13/16
CHLM
09/13/16
NO CHANGE
CHLM
LabCorp impact from Quest-Optum collaboration limited, says Craig-Hallum
Craig-Hallum analyst Bill Bonello said the Quest Diagnostics (DGX) and Optum, a division of United Healthcare (UNH), collaboration does not put LabCorp's (LH) revenue at risk. The collaboration does not create any lab benefit management service, or a preferred lab network with Quest at the hub, that would drive business to Quest labs or compete with Labcorp's Beacon LBS lab management business, the analyst wrote. Bonellow said UnitedHealthcare and LabCorp continue to work together to expand the Beacon LBS model to other markets and we would expect to see the Beacon lab network expand to other payors overtime. Also, the analyst said the collaboration does not impact LabCorp's contract with UnitedHealthcare, or UHC, and and has no impact on that contract today and does not imply a change to UHC's contracting strategy going forward. Bonello rates LabCorp a Buy with a $160 price target.
09/14/16
ADAM
09/14/16
NO CHANGE
Target $155
ADAM
Buy
LabCorp weakness a buying opportunity, says Canaccord
Canaccord analyst Mark Massaro noted LabCorp (LH) shares sold off yesterday on news that its rival, Quest Diagnostics (DGX), announced a partnership with Optum, a subsidiary of UnitedHealth (UNH). The analyst said LabCorp does not believe Quest can wrestle away UnitedHealth's long-standing lab services contract when it goes up for renewal in 2018. Massaro expects LabCorp to deliver steady quarterly beats and said the company is well positioned to capture its losses in the second half of 2016. Massaro reiterated his Buy rating and $155 price target on LabCorp shares.
09/22/16
PIPR
09/22/16
NO CHANGE
Target $155
PIPR
Overweight
UnitedHealth won VA contract worth $1B per year, says Piper Jaffray
Piper Jaffray analyst Sean Wieland says UnitedHealth unit Optum has won a contract with the U.S. Department of Veterans Affairs to provide medical disability examinations. The analyst estimates the contract, awarded to Optum wholly owned subsidiaries Logistics Health and Medical Support Los Angeles, represents $1B per year. Wieland estimates the award will be neutral to earnings in year one and become accretive in 2018. He reiterates an Overweight rating on UnitedHealth shares with a $155 price target.
09/22/16
EVER
09/22/16
INITIATION
Target $155
EVER
Buy
UnitedHealth initiated with a Buy at Evercore ISI
Evercore ISI initiated UnitedHealth with a Buy and a $155 price target.

TODAY'S FREE FLY STORIES

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

16:47
06/27/17
06/27
16:47
06/27/17
16:47
Hot Stocks
Global Medical REIT provides update on acquisition of cardiac clinic in Lubbok »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:46
06/27/17
06/27
16:46
06/27/17
16:46
Hot Stocks
Ryerson comments on Q2 market conditions, demand environment »

In a press release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:43
06/27/17
06/27
16:43
06/27/17
16:43
Earnings
Ryerson sees Q2 net income $0M-$2M »

EPS consensus 35c. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
06/27/17
06/27
16:38
06/27/17
16:38
General news
API crude inventories for week of June 23 »

API reports that crude…

SSTK

Shutterstock

$43.81

-0.94 (-2.10%)

16:37
06/27/17
06/27
16:37
06/27/17
16:37
Hot Stocks
Shutterstock to acquire Flashstock for approximately $50M cash »

Shutterstock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$77.77

0.26 (0.34%)

16:36
06/27/17
06/27
16:36
06/27/17
16:36
Hot Stocks
Aflac recommends shareholders to reject mini-tender offer by TRC Capital »

Aflac announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$36.97

0.13 (0.35%)

, BA

Boeing

$198.89

-1.09 (-0.55%)

16:34
06/27/17
06/27
16:34
06/27/17
16:34
Hot Stocks
Air Lease delivers Boeing 737-800 to Travel Service »

Air Lease Corporation…

AL

Air Lease

$36.97

0.13 (0.35%)

BA

Boeing

$198.89

-1.09 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CEMI

Chembio Diagnostics

16:33
06/27/17
06/27
16:33
06/27/17
16:33
Syndicate
Chembio establishes "at-the-market" program »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

OC

Owens Corning

$66.05

-0.65 (-0.97%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Owens Corning completes acquisition of Pittsburgh Corning for $560M »

Owens Corning announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLLS

Cellectis

$24.34

-0.69 (-2.76%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Cellectis announces first in human administration in AML study »

Cellectis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NSAT

Norsat

$11.50

0.1 (0.88%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Norsat receives court approval for arrangement with Hytera Communications »

Norsat International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$4.85

0.01 (0.21%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Meet Group reaches agreement with Harvest Capital »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/27/17
06/27
16:30
06/27/17
16:30
Options
Preliminary option volume of 15.8M today »

Preliminary option volume…

16:25
06/27/17
06/27
16:25
06/27/17
16:25
Conference/Events
CFA Society of North Carolina to hold a panel discussion »

The CFA Society of North…

CVS

CVS Health

$80.49

0.37 (0.46%)

16:20
06/27/17
06/27
16:20
06/27/17
16:20
Initiation
CVS Health initiated  »

CVS Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
Initiation
Walgreens Boots Alliance initiated  »

Walgreens Boots Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

S

Sprint

$8.18

0.17 (2.12%)

, TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
General news
On The Fly: Top stock stories for Tuesday »

Stocks moved in a very…

S

Sprint

$8.18

0.17 (2.12%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

CMCSA

Comcast

$39.25

-0.34 (-0.86%)

CHTR

Charter

$329.87

-2.78 (-0.84%)

VZ

Verizon

$44.84

-0.91 (-1.99%)

T

AT&T

$37.70

-0.45 (-1.18%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

MRK

Merck

$65.54

-0.38 (-0.58%)

MDLZ

Mondelez

$43.97

-0.93 (-2.07%)

WPPGY

WPP PLC

$104.96

-0.97 (-0.92%)

FDX

FedEx

$214.39

-0.97 (-0.45%)

CBI

CB&I

$20.02

5.62 (39.03%)

DRI

Darden

$92.69

2.61 (2.90%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

STX

Seagate

$39.51

-2.88 (-6.79%)

RARX

RA Pharmaceuticals

$17.69

-4.49 (-20.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 07

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 21

    Sep

  • 22

    Sep

CEMI

Chembio Diagnostics

16:18
06/27/17
06/27
16:18
06/27/17
16:18
Syndicate
Breaking Syndicate news story on Chembio Diagnostics »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

$NSD

NASDAQ Market Internals

16:17
06/27/17
06/27
16:17
06/27/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$23.32

-0.61 (-2.55%)

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Initiation
Square initiated  »

Square assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

$NYE

NYSE Market Internals

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$52.73

-1.01 (-1.88%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
PayPal initiated  »

PayPal assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

CFI

Culp

$32.25

-0.25 (-0.77%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Hot Stocks
Culp changes NYSE ticker symbol to 'CULP' »

Culp, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAWK

Blackhawk

$41.90

-1.1 (-2.56%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
Blackhawk initiated  »

Blackhawk initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$109.76

-1.25 (-1.13%)

16:14
06/27/17
06/27
16:14
06/27/17
16:14
Hot Stocks
UPS to freeze retirement plan benefits for non-union employees »

United Parcel Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.